title: Results from the Endologix PowerLink multicenter trial.
abstract: The Endologix PowerLink system is a one-piece, bifurcated, fully supported endoluminal graft for the treatment of abdominal aortic aneurysms (AAA). In a recently completed multicenter trial, the device has proven to be effective with a high technical success rate, low morbidity and mortality rates, and a mean decrease in AAA size over time. A 16-month mean follow-up has found low endoleak and migration rates. There have been no ruptures to date. The Endologix PowerLink device compares favorably with previously published results of other endoluminal grafts.
authors.affiliation: Division of Vascular Surgery, Harbor-UCLA Medical Center, 1000 West Carson Street, Torrance, CA 90509, USA.
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Hansen
authors.forename: Ihab
authors.initials: I
authors.lastname: Aziz
authors.forename: Benjamin B
authors.initials: BB
authors.lastname: Kim
authors.forename: Carlos E
authors.initials: CE
authors.lastname: Donayre
authors.forename: Rodney A
authors.initials: RA
authors.lastname: White
mesh_terms: D017130:Angioplasty / Q000009:adverse effects*; D017544:Aortic Aneurysm, Abdominal / Q000601:surgery*; D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D019917:Blood Vessel Prosthesis Implantation / Q000009:adverse effects*; D006801:Humans; D011138:Polytetrafluoroethylene / Q000627:therapeutic use; D011183:Postoperative Complications / Q000209:etiology; D011475:Prosthesis Failure; D015607:Stents / Q000009:adverse effects*; D016896:Treatment Outcome; D014481:United States
chemical_list: D011138:Polytetrafluoroethylene